{"doi":"10.33696/immunology.1.021","title":"Targeting Mesothelin in Pancreatic Ductal Adeno- Carcinoma PDAC","abstract":null,"journal":"Journal of Cellular Immunology","year":2020,"id":625837,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Targeting Mesothelin in Pancreatic Ductal Adeno- Carcinoma PDAC","abstract":"Pancreatic Ductal Adenocarcinoma (PDAC) represents 90% of all pancreatic malignancies . To date, PDAC is the fourth leading cause of cancer-related death and its incidence is rising to become the second one in the next decade","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19910364","pmcid":null,"openalex_id":"https://openalex.org/W3017358131","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.03346423,"influential_citations":0,"citation_trend":[],"oa_status":"hybrid","license":"cc-by","oa_locations":[{"url":"https://www.scientificarchives.com/admin/assets/articles/pdf/targeting-mesothelin-in-pancreatic-ductal-adeno--carcinoma-pdac-20200401020402.pdf","host_type":"journal"},{"url":"https://www.scientificarchives.com/admin/assets/articles/pdf/targeting-mesothelin-in-pancreatic-ductal-adeno--carcinoma-pdac-20200401020402.pdf","host_type":"publisher"},{"url":"https://doi.org/10.33696/immunology.1.021","host_type":"journal"}],"fields_of_study":["Pancreatic and Hepatic Oncology Research","Cancer Research and Treatments","Cancer Cells and Metastasis"],"mesh_terms":[],"keywords":["Pancreatic ductal adenocarcinoma","Mesothelin","Pancreatic carcinoma","Medicine","Pancreatic cancer","Oncology","Internal medicine","Incidence (geometry)","Adenocarcinoma","Cancer","Cancer research"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T11:10:10.163943Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}